Navigation Links
Berlin Heart Announces Restructuring of Management

BERLIN, July 7 /PRNewswire/ -- Ulrich Stroeher, Chairman of the Advisory Board of Berlin Heart, today announced that Dr. Johannes Mueller is leaving the general management of the company on 30 September 2009.

Dr. Mueller belongs to the company's founders and is one of the intellectual fathers of the successful ventricular assist device INCOR(R). He will continue to contribute his wealth of experience in this area as coordinator for projects with external cooperation partners. He will further support the company in developing new markets.

Dr. Mueller was a member of the general management from the very beginning when the company was founded as a start-up enterprise with venture capital in 1996. In October 2006 Berlin Heart AG was acquired by Syscore GmbH and the legal structure was changed to GmbH. Today Berlin Heart has 220 employees and is one of the three worldwide leading medical device companies in the area of mechanical heart support.

On 1 October 2009 Dr. Stefan Thamasett will join the general management of Berlin Heart. Dr. Thamasett has more than seven years of experience in clinical cardiology and possesses long-standing experience as head of marketing and sales in well-known medical device companies. He will manage the company together with Dr. Dirk Lauscher, the company's present General Manager.

About Berlin Heart

Berlin Heart is the only company worldwide that develops, produces, and distributes implantable and external ventricular assist devices for patients of every age and body size. The products EXCOR(R) and INCOR(R) provide mechanical support of the heart for patients suffering from severe end-stage heart failure. The ventricular assist device EXCOR(R) Pediatric is used in infants, children, and teenagers and is leading the worldwide market. EXCOR(R) Pediatric is currently under clinical investigation for pediatric patients in USA. All other products are not approved in USA. Further information on the Berlin Heart products is available under:

Contact: Linda Buerk Manager Marketing & PR Phone: +49-(0)30-8187-2650 Mobile: +49-(0)173-629-0803

SOURCE Berlin Heart GmbH
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Charterhouse Group Partners with MTS Health Investors and Highlander Partners to Acquire Chamberlin Edmonds & Associates, Inc., a Leading Provider of Eligibility Services to Hospitals
2. Berlin Heart Receives First Regulatory Approval in North America
3. Drug for cluster headaches may cause heart problems
4. Use of certain lipid measures not more effective in predicting coronary heart disease
5. Restricting Blood Flow May Help Heart Bypass Patients
6. Urban Smog Tough on Young Adults Hearts
7. Stanford study highlights cost-effective method of lowering heart disease risks
8. Vitamin Es lack of heart benefit linked to dosage
9. Drug That Lowers Resting Heart Rate Being Tested
10. Heart Attack Boosts Diabetes Risk
11. Embryonic Stem Cells Repair Human Heart
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert ... Organizations, One Beat ” campaign. The partnership between the two groups began in 2014 ... MAP International’s cause. , MAP International was founded in 1954 and is an international ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug rehabilitation ... new cutting edge recovery program that has been 50 years in the making. ... with the purpose to free addicts from the symptoms and negative behaviors of addiction. ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for ... aware of the benefits of Botox® in the treatment of moderate facial wrinkling, few ... and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted by an ... IL, UV Angel is evaluating the efficacy of its product and its disinfection protocol. ... 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical ...
(Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 2015 Kitov Pharma ceuticals ... a biopharmaceutical company focused on the development of therapeutic ... today announced the closing of its previously announced underwritten ... ), each representing 20 ordinary shares of the Company, ... ADSs and warrants were issued in a fixed combination ...
(Date:11/25/2015)...  Today AVACEN Medical announced the issue of United States patent No. ... ". This patent shields the company,s AVACEN 100 dry heat therapy medical device and specific methods ... Photo - ... ... ...
(Date:11/25/2015)... , Nov. 25, 2015 USP 800 ... drug preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, ... technicians). The chapter also covers all entities which ... pharmacies, hospitals, other healthcare institutions, patient treatment clinics, ... --> --> What is ...
Breaking Medicine Technology: